Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02787954 · ClinicalTrials.gov registry record
Prospective Tumor Response Evaluation
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- 10
- Enrollment target
NCT02787954: Clinical Trial study, sponsored by The University of Texas Health Science Center, Houston.
NCT02787954 is a clinical trial that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02787954 was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if MRI imaging can detect genetic, proteomic, and metabolomic characteristics of liver tumors. The study also aims to determine if these imaging characteristics are correlated with clinical outcomes.
Primary Outcome
Time from initial treatment to progression as defined by RECIST criteria.
Interventions
- PROCEDURE TACE
- PROCEDURE Y-90
- PROCEDURE MWA
- PROCEDURE IRE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-04 |
Why NCT02787954 stopped before completion
NCT02787954 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which TACE is the first listed.
NCT02787954 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02787954 about?
NCT02787954 is a clinical study titled "Prospective Tumor Response Evaluation". The purpose of this study is to determine if MRI imaging can detect genetic, proteomic, and metabolomic characteristics of liver tumors. The study also aims to determine if these imaging characteristics are correlated with clinical outcomes.
What is the current status of trial NCT02787954?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2016-01. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02787954?
The interventions under investigation include: TACE (PROCEDURE), Y-90 (PROCEDURE), MWA (PROCEDURE), IRE (PROCEDURE).
Who is sponsoring clinical trial NCT02787954?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia